EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tau seeds occur before earliest Alzheimer’s changes and are prevalent across neurodegenerative diseases

Matteo Manca, Heidi G Standke, Danielle F Browne, Mikayla L Huntley, Olivia R Thomas, Christina D Orrú, Andrew G Hughson, Yongya Kim, Jing Zhang, Curtis Tatsuoka, Xiongwei Zhu, Annie Hiniker und 3 weitere

Acta Neuropathologica · 2023

DOI: 10.1007/s00401-023-02574-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neuropathologica, 2023. Verfasst von Matteo Manca und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Case Western Reserve University School of Medicine, 2103 Cornell Road, Cleveland, OH, 44106, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Neurodegenerative Diseases, Synucleinopathies, Tauopathies. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIA NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tau neurofibrillary tangles are a hallmark of Alzheimer’s disease neuropathological change. However, it remains largely unclear how distinctive Alzheimer’s disease tau seeds (i.e. 3R/4R) correlate with histological indicators of tau accumulation. Furthermore, AD tau co-pathology is thought to influence features and progression of other neurodegenerative diseases including Lewy body disease; yet measurements of different types of tau seeds in the setting of such diseases is an unmet need. Here, we use tau real-time quaking-induced conversion (RT-QuIC) assays to selectively quantitate 3R/4R tau seeds in the frontal lobe which accumulates histologically identifiable tau pathology at late disease stages of AD neuropathologic change. Seed quantitation across a spectrum of neurodegenerative disease cases and controls indicated tau seeding activity can be detected well before accompanying histopathological indication of tau deposits, and even prior to the earliest evidence of Alzheimer’s-related tau accumulation anywhere in the brain. In later stages of AD, 3R/4R tau RT-QuIC measures correlated with immunohistochemical tau burden. In addition, Alzheimer’s tau seeds occur in the vast majority of cases evaluated here inclusive of primary synucleinopathies, frontotemporal lobar degeneration and even controls albeit at multi-log lower levels than Alzheimer’s cases. α-synuclein seeding activity confirmed synucleinopathy cases and further indicated the co-occurrence of α-synuclein seeds in some Alzheimer’s disease and primary tauopathy cases. Our analysis indicates that 3R/4R tau seeds in the mid-frontal lobe correlate with the overall Braak stage and Alzheimer’s disease neuropathologic change, supporting the quantitative predictive value of tau RT-QuIC assays. Our data also indicate 3R/4R tau seeds are elevated in females compared to males at high (≥ IV) Braak stages. This study suggests 3R/4R tau seeds are widespread even prior to the earliest stages of Alzheimer’s disease changes, including in normal, and even young individuals, with prevalence across multiple neurodegenerative diseases to further define disease subtypes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseNeurodegenerative DiseasesSynucleinopathiesTauopathiesFemaleHumansMalealpha-Synucleintau Proteins

Stichwörter der Autor:innen

Alpha-synucleinAlzheimer’s diseaseProtein seedsRT-QuICSynucleinopathyTauTauopathy

Substanzen

alpha-Synucleintau ProteinsMAPT protein, human

Autor:innen und Institutionen

  • Department of Pathology, Case Western Reserve University School of Medicine, 2103 Cornell Road, Cleveland, OH, 44106, USA.
  • Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, 59840, USA.
  • Department of Neurosciences, University of California San Diego, San Diego, CA, 92093-0612, USA.
  • Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, 44106, USA.
  • Department of Medicine, University of Pittsburgh, Pittsburgh, PA, 15232, USA.
  • Department of Pathology, University of California San Diego, San Diego, CA, 92093-0612, USA.

ORCID-Profile: Allison Kraus

Förderung

  • NIH HHS
  • NIA NIH HHS
  • NINDS NIH HHS
  • National Institute of Neurological Disorders and Stroke
  • National Institute on Aging
  • Biomarkers across neurodegenerative diseases
  • Alzheimer's Association
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Zitieren

APA

Manca, M., Standke, H. G., Browne, D. F., Huntley, M. L., Thomas, O. R., Orrú, C. D., Hughson, A. G., Kim, Y., Zhang, J., Tatsuoka, C., Zhu, X., Hiniker, A., Coughlin, D. G., Galasko, D., & Kraus, A. (2023). Tau seeds occur before earliest Alzheimer’s changes and are prevalent across neurodegenerative diseases. Acta Neuropathologica. https://doi.org/10.1007/s00401-023-02574-0

Vancouver

Manca M, Standke HG, Browne DF, Huntley ML, Thomas OR, Orrú CD, et al. Tau seeds occur before earliest Alzheimer’s changes and are prevalent across neurodegenerative diseases. Acta Neuropathologica. 2023. doi:10.1007/s00401-023-02574-0

BibTeX
@article{Manca2023,
  author = {Manca, Matteo and Standke, Heidi G and Browne, Danielle F and Huntley, Mikayla L and Thomas, Olivia R and Orrú, Christina D and Hughson, Andrew G and Kim, Yongya and Zhang, Jing and Tatsuoka, Curtis and Zhu, Xiongwei and Hiniker, Annie and Coughlin, David G and Galasko, Douglas and Kraus, Allison},
  title = {Tau seeds occur before earliest Alzheimer’s changes and are prevalent across neurodegenerative diseases},
  journal = {Acta Neuropathologica},
  year = {2023},
  doi = {10.1007/s00401-023-02574-0}
}
Kostenlos starten →